VEIN TREATMENTS  
 
Non Surgical Treatment >>
Possible Side Effects of Non-Surgical Vein Treatments >>
Possible Complications of Non-Surgical vein Treatment  >>
Precautions >>
How Successful is Non-Surgical Vein Treatment? >>
Treatment Information – preparation before treatment and post-treatment instructions >>
Are there alternative treatment methods? >>
Fee Structure >>
Disclaimer >>
References >>
 

 
References
  1. Varcoe Paul F Australian & New Zealand Journal of Phlebology. Dec 2003: Volume 7:17-24
  2. Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster DC, Whitaker DC, Butler B, Lowery BJ, Guidelines of care for sclerotherapy treatment of varicose and teleangiectactic leg veins. J Am Dermatol 1996; 34:523-528
  3. Rabe E (Hrsg): Grundlagen der Phlebologie.2. Auflage, Viavital,Koln 2000
  4. Baccaglini U, Spreaficano G, Castoro c, Sorrentino P: Consensus Conference on Sclerotherapy of varicose veins of the lower limbs.Phlebology 1997; 12: 2-16
  5. Conrad P, malouf GM, Stacey MC: The Australian Polidocanol Study. Results at 1 year. Phlebology 1994: 9: 17-20
  6. Goldman PM: Polidocanol for Sclerotherapy of Superficial venules and Teleangiectasias. J Dermatol Surg Oncol 1989; 15: 204-209
  7. Einarsson E, Eklof B, Neglen P: Sclerotherapy or Surgery as treatment for varicose veins: A Prospective randomized Study. Phlebology 1993; 8: 22-26
  8. Frullini A, Cavezzi A: Ultrasound Guided Sclerotherapy in the treatment of long saphenous vein insufficiency. Vasomed 1999; 11, Suppl. 1:8
  9. Kreussler: Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische fabrik Kreussler & Co Gmbh, Stand 2/1996
  10. Vin F: Priciples de la Sclerotheraphie des Troncs Saphenes Internes. Phlebologie 1997; 50(2): 229-34
  11. Cavezzi A, Frullini A: Echosclerotherapy in the short saphenous vein insufficiency: personal experience. Abstract UIP, Sydney 1998
  12. Goldmann PM: Complications of Sclerotherapy. In: Gloviczki,P,J yao (eds): Handbook of venous Disorders. Chapmann & Hall Medical, London, 1996, 374-93
  13. Hohlbaum G;Uber iatrogene Schaden be der Varizensklerosierung. In: Staubesand J, E Schopf (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer Verlag, Berlin Heidelberg, New York, 1990, 70-81
  14. Saydewitz V, Staubesand J: Das ultrastrukturelle Substrat der Wirkung paravasi und intraarterial applizieter Sklerosierungsmittel: Ein experimenteller Beitrag zum Problem iatrogener Schaden nach Sklerotherapie. In: Staubesand J, E Schopf (Hrsg): Neuere Aspekte der Sklerosierungstherapie. Springer, Heidelberg, 1990: 40-65
  15. Weiss RA, Weiss MA: Incidence of Side Effects in the treatment of Telegiectasias by compression sclerotherapy: Hypertonics Saline vs Polidocanol. J Dermatol Surg Oncol 1990; 16: 800-804
  16. Fisher DA: Regarding Extensive Tissue Necrosis Following High Concentration Sclerotherapy for varicose veins. Dermatol Surg 2000; 26 (11): 1081
  17. Goldman PM, Beaudoing D, Marley W, Lopez L, Butie A: Compression in the treatment of Leg Telegiectasias : A Preliminary report. J dermatol Surg Oncol 1990: 16: 322-325
  18. Goldman MP, sadick NS, Weiss RA: Cutaneous necrosis, Teleangiectatic matting and Hyperpigmentation following sclerotherapy. Dermatol Surg 1995; 21: 19-29
  19. Weiss RA, Sadick NS.Goldman MP, Weiss MA: Post-sclerotherapy compression: controlled comparitive study of duration of compression and its effects on clinical outcome. Dermatol Surg 1999; 25: 105-108
  20. Van der plas JPL, lambers JC, van wersch JW, Koehler PJ: reversible ishaemic neurological defecit after sclerotherapy of varicose veins. Lancet 1994; 343:428
  21. Baccaglini U, Stemmer R, Partsch U: Internarionale Fragenbogenaktion zur Praxis der Verodungsbehandlung. Phlebologie 1997; 26: 129-142
  22. Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, hashemiyoon RB: Allergic reactions to Polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994:20:466-468
  23. Fuerstein W: Schwere Anaphylktische Reaktion auf Hydroxypolaethoxydodecan. VASA 1973;3 (2) 292-294
  24. Pradalier A, Vincent D, Hentschel V, Cohen-Jonathan AM, Daniel E: Allergie aux sclerosants des varices. Rev. Fr. Allergol. 1995;35(5): 440-443
  25. OeshA, Stirnemann P, Mahler F: The Acute Iscahemic Syndrome of the foot after Sclerotherapy of varicose veins. Schweiz. Med. Wochenschr 1984; 114: 1155-1158
  26. Bergan JJ, Weiss RA, Goldman MP: Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 2000; 26:535-542
  27. Gorgiev M: Post sclerotherapy Hyperpigmentations. J Dermatol Surg oncol 1993; 19:649-652
  28. Villavicencio J, Pfeifer J, Lohr J, Goldman M, Cranley R, Spence R: Sclerotharpy for varicose veins: Practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J (EDS): handbook of venous Disorders. Chapman & hall medical, London 1996 337-54
  29. Fegan WG: Continous compression technique of infecting varicose veins. Lancet 1963; 109-112
  30. Reddy P, Wickers J, Terry T, lamont P, Moller J, Dormandy JA: What is the correct period pf bandaging following sclerotherapy? Phlebology 1986; 217-220
  31. Grondin L, R Yound, L Wouters: Sclerotherapie echo-guidee et securite: Comparison des techniques. Phlebologie 1997: 50 (2) 241-45
  32. Guex JJ: Ultrasound Guided Sclerotherapy (USGS) for perforating veins. Hawaii med J 2000; 59(6): 261-262
  33. Schadeck M: Duplex-Kontrollierte Sklerosierungsbehandlung der vena saphena magna. Phlebologie 1996; 25: 78-82
  34. Schadeck M, Allaert FA: Resultats a long terme de la Sclerotherapie des Saphenes internes. Phlebologie 1997; 50(2); 257-262
  35. Schadeck m: Echo-Sclerotherpay. Phelobologie 1999;52(Special Issue 10); 103-106
  36. Hamel-Desnos c, Desnos P, Ouvry P: Nouveautes therapeutiques dans la prise en charge de la maladie variqeuese: echo-sclerotherapie et mousse. Phlebologie 2003 56(1): 41
  37. Frullini A: Sclerosing foam in the treatment of recurrent varicose veins in: Hrsg: Henriet J P, foam sclerotherapy state of the art. Editions Phlebologiques Francaises, 73-78
  38. Gobin J P: The sclerotherapy position in recurrent varicose veins treatment Int Angiology 20,2, Suppl1, and 336, UIP 01,09-14.09.2001, Rome
  39. Hartel SL: Funf-Jahres Nachuntersuchungsergebnisse der Sklerosierungstherapie nach Stemmer bei 118 Patienten mit primarer varikosis. Vasomed 1998:4:272-273
  40. Hubner K: Ambulante Therapie der Stammvarikose mittels Krossektomie und Slerotherapie-ein Beitrag aus der Praxis des neidergelassenen Phlebologen. Phlebologie 1991; 20: 104-108
  41. Malouf GM: Ambulatory Venous Surgery vs Sclerotherapy. Hawaii med J 2000; 59:248-249
  42. Shultz-Ehrenburg U, Tourbier H: Doppler-Kontrollierte Verodungsbehandlung der vena saphena Magna. Phlebol u Proktol 1984; 13: 117-122
  43. McCoy s, Evans A, Spurrier N: Sclerotherapy for leg Telegiectasia-A Blinded Comparitive trial of Polidocanol and hypertonic saline. Dermatol Surg 1999; 25:381-386
  44. Norris MJ, Carlin MC, Ratz JL: Treatment of essential telangiectasia: Effects of increasing concentration s of polidocanol. J Am Acad of dermatol 1989; 20(4): 643-649
  45. Tazelaar DJ, HAM Neumann, KP De Roos: long cotton wool rolls as compression enhancers in macrosclerotherapy for varicose veins. Dermatol Surg 1999; 25(1): 38-40
  46. DoverJ, Sadick N, MP Goldman: The role of lasers and light sources in the treatment of leg veins. Dermatol Surg 1999;25: 328-336
  
     
 
Vein Solutions Centres: Kew Narre Warren

email us